ArticleHealth services research2007
Utilizing new prescription drugs: disparities among non-Hispanic whites, non-Hispanic blacks, and Hispanic whites.
Article in Health services research, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 47 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
47 citing papers in PubMed.
- Racial and Ethnic Disparities in the Use of Expensive Medications: A Focus on Sugammadex in the Pediatric Perioperative Setting.The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG · 2026Article
- Racial Inequity in Prescription of Semaglutide Among Eligible People With HIV.Diabetes care · 2025Article
- Evidence-based SGLT2 inhibitor and GLP-1 receptor agonist use by race in the VA healthcare system.American journal of preventive cardiology · 2025Article
- Effects of SGLT2 Inhibitors on Cardiac Mechanics in Hispanic and Black Diabetic Patients.Journal of clinical medicine · 2024Article
- Cancer Incidence Trends in Successive Social Generations in the US.JAMA network open · 2024Article
- Impact of race and social determinants of health on outcomes in patients with aggressive B-cell NHL treated with CAR-T therapy.Blood advances · 2024Article
- REPRESENTATION AND EXTRAPOLATION: EVIDENCE FROM CLINICAL TRIALSThe quarterly journal of economics · 2024Article
- Effects of star ratings bonus payments on disparities in medication utilization issues.Exploratory research in clinical and social pharmacy · 2023Article
- Solving racial/ethnic disparities associated with Medicare Part D Star Ratings.Current medical research and opinion · 2023Article
- Racial and ethnic disparities in the enrolment of medicare medication therapy management programs.Journal of pharmaceutical health services research : an official journal of the Royal Pharmaceutical Society of Great Britain · 2023Article
- Patterns and disparities in prescribing of opioids and benzodiazepines for older adults in North Carolina.Journal of the American Geriatrics Society · 2023Article
- Racial and Ethnic Differences in Antiseizure Medications Among People With Epilepsy on Medicaid: A Case of Potential Inequities.Neurology. Clinical practice · 2023Article
- Immigrant IBD Patients in Spain Are Younger, Have More Extraintestinal Manifestations and Use More Biologics Than Native Patients.Frontiers in medicine · 2022Article
- Second-Line Therapy for Type 2 Diabetes Management: The Treatment/Benefit Paradox of Cardiovascular and Kidney Comorbidities.Diabetes care · 2021Article
- Integrase Inhibitor Prescribing Disparities in the DC and Johns Hopkins HIV Cohorts.Open forum infectious diseases · 2021Article
- Comparison of Diabetes Medications Used by Adults With Commercial Insurance vs Medicare Advantage, 2016 to 2019.JAMA network open · 2021Article
- Disparities in the appropriateness of medication use: Analysis of the REasons for Geographic And Racial Differences in Stroke (REGARDS) population-based cohort study.Research in social & administrative pharmacy : RSAP · 2020Article
- Medication Complexity among Disadvantaged African American Seniors in Los Angeles.Pharmacy (Basel, Switzerland) · 2020Article
- Adoption of New Glucose-Lowering Medications in the U.S.-The Case of SGLT2 Inhibitors: Nationwide Cohort Study.Diabetes technology & therapeutics · 2019Article
- Obesity and Polypharmacy among African American Older Adults: Gender as the Moderator and Multimorbidity as the Mediator.International journal of environmental research and public health · 2019Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
objectiveTo examine racial and ethnic disparities in new prescription drug use. DATA SOURCES/STUDY
settingSecondary data analyses of the Medical Expenditure Panel Survey (1996-2001), a national survey representative of U.S. noninstitutionalized civilian population. Drug approval dates were from the GenRx database of Mosby. STUDY
designA negative binomial model was used to compare annual number of times when new drugs were obtained across racial and ethnic groups. Covariates in the model were demographic, economic characteristics, and health status. Drugs were considered new if approved within the past 5 years. We compared non-Hispanic whites with non-Hispanic blacks, and non-Hispanic whites with Hispanic whites, respectively, to examine racial and ethnic disparities separately. PRINCIPAL
findingsDescriptive analyses found smaller racial disparities than ethnic disparities: the average annual number of times when new drugs were obtained was higher among non-Hispanic whites than non-Hispanic blacks (1.71 versus 1.36; p<.01) and Hispanic whites (1.71 versus 1.11; p<.01). Multivariate analyses found smaller ethnic than racial disparities: the number was 22-33 percent lower among non-Hispanic blacks than non-Hispanic whites (significant), and 5-16 percent lower among Hispanic whites than non-Hispanic whites (not always significant), respectively. While the absolute racial disparities decreased over the early years of the life cycles of the products, the reduction in disparities over time was not significant.
conclusionsThere are racial disparities in the use of new medications, which persist during the first 5 years of marketing. Socioeconomic and health characteristics account for a larger share of ethnic disparities than racial disparities.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.